Vincerx Pharma, Inc.

Historical 13F Holders

Symbol
VINC
CUSIP
92731L106
All holders as of
Q4 2024
Type
Equity
Class
COM NEW
Reported Value, Excluding Options
Total Shares Held, Excluding Options
Total Filers

13D/G Filers

Each filer's latest filing for 92731L106 since 12/18/2024, largest first.

Filer % of Class Filed
Under 5%, checked the "5 percent or less" box, or amended by a later filing (2)
Sage Rhino Capital, LLC 13G/A 0% 7/29/2025
Event 1/29/2025
Long Focus Capital Management, LLC 13G/A
0% 2/11/2025
Event 12/31/2024

13F Holders by Quarter

Period Filers Shares, Excl. Options Value, Excl. Options
2024 Q4 21 4.81 M $1.26 M
2024 Q3 27 11.0 M $7.89 M
2024 Q2 29 10.7 M $8.66 M
2024 Q1 39 8.50 M $42.9 M
2023 Q4 34 12.0 M $14.1 M
2023 Q3 35 10.7 M $10.8 M
2023 Q2 35 12.1 M $15.7 M
2023 Q1 36 12.8 M $13.3 M
2022 Q4 35 12.8 M $13.1 M
2022 Q3 44 14.5 M $20.0 M
2022 Q2 50 13.9 M $18.4 M
2022 Q1 66 16.3 M $65.1 M
2021 Q4 56 15.4 M $157 M
2021 Q3 56 15.4 M $249 M
2021 Q2 57 12.1 M $157 M
2021 Q1 37 9.16 M $177 M
2020 Q4 19 3.80 M $79.5 M